HK1129668A1 - - Google Patents
Info
- Publication number
- HK1129668A1 HK1129668A1 HK09107754.2A HK09107754A HK1129668A1 HK 1129668 A1 HK1129668 A1 HK 1129668A1 HK 09107754 A HK09107754 A HK 09107754A HK 1129668 A1 HK1129668 A1 HK 1129668A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- intensity
- given
- diffractometer
- theta
- exhibited
- Prior art date
Links
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 2
- 238000002441 X-ray diffraction Methods 0.000 abstract 2
- 229910052802 copper Inorganic materials 0.000 abstract 2
- 239000010949 copper Substances 0.000 abstract 2
- 238000010586 diagram Methods 0.000 abstract 2
- RYCSJJXKEWBUTI-YDYAIEMNSA-N perindopril arginine Chemical class OC(=O)[C@@H](N)CCCNC(N)=N.C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 RYCSJJXKEWBUTI-YDYAIEMNSA-N 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 239000005541 ACE inhibitor Substances 0.000 abstract 1
- 229940086440 Angiotensin I converting enzyme inhibitor Drugs 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0601747A FR2897865B1 (fr) | 2006-02-28 | 2006-02-28 | Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| PCT/FR2007/000334 WO2007099216A2 (fr) | 2006-02-28 | 2007-02-26 | FORME CRISTALLINE β DU SEL D'ARGININE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1129668A1 true HK1129668A1 (bg) | 2009-12-04 |
Family
ID=37198804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK09107754.2A HK1129668A1 (bg) | 2006-02-28 | 2009-08-24 |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US7923569B2 (bg) |
| EP (1) | EP2016051B1 (bg) |
| JP (1) | JP5611524B2 (bg) |
| KR (1) | KR20080106947A (bg) |
| CN (1) | CN101389604B (bg) |
| AT (1) | ATE465992T1 (bg) |
| AU (1) | AU2007220434B2 (bg) |
| BR (1) | BRPI0708291B8 (bg) |
| CA (1) | CA2643803C (bg) |
| CY (1) | CY1110082T1 (bg) |
| DE (1) | DE602007006176D1 (bg) |
| DK (1) | DK2016051T3 (bg) |
| EA (1) | EA014715B1 (bg) |
| ES (1) | ES2345291T3 (bg) |
| FR (1) | FR2897865B1 (bg) |
| GE (1) | GEP20135839B (bg) |
| HK (1) | HK1129668A1 (bg) |
| HR (1) | HRP20100357T1 (bg) |
| MA (1) | MA30277B1 (bg) |
| ME (1) | ME01805B (bg) |
| MX (1) | MX2008010747A (bg) |
| MY (1) | MY143557A (bg) |
| NO (1) | NO341238B1 (bg) |
| NZ (1) | NZ570366A (bg) |
| PL (1) | PL2016051T3 (bg) |
| PT (1) | PT2016051E (bg) |
| RS (1) | RS51431B (bg) |
| SI (1) | SI2016051T1 (bg) |
| UA (1) | UA89904C2 (bg) |
| WO (1) | WO2007099216A2 (bg) |
| ZA (1) | ZA200807025B (bg) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2897866B1 (fr) | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| AU2013245523C1 (en) * | 2008-06-24 | 2017-09-07 | Mylan Laboratories Ltd | Novel polymorphic forms of Perindopril (L)-Arginine and process for the preparation thereof |
| SI2318365T1 (sl) * | 2008-06-24 | 2016-01-29 | Mylan Laboratories Limited | Nove polimorfne oblike perindopril (l) - arginina in postopek za pripravo |
| AU2009212902A1 (en) | 2008-09-03 | 2010-03-18 | Apotex Pharmachem Inc. | Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof |
| FR2985511B1 (fr) * | 2012-01-05 | 2014-01-03 | Servier Lab | Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| FR2985512B1 (fr) * | 2012-01-05 | 2014-06-20 | Servier Lab | Procede de preparation du sel de l-arginine du perindopril |
| CN103172696B (zh) * | 2012-12-19 | 2014-12-17 | 宁波美诺华药业股份有限公司 | 一种γ晶型的培哚普利精氨酸盐的制备方法 |
| WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
| FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
| EP3842035A1 (en) | 2019-12-23 | 2021-06-30 | KRKA, d.d., Novo mesto | Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules |
| SI26268A (sl) | 2021-11-18 | 2023-05-31 | Zupet Rok | Postopek za pripravo hidratirane oblike perindopril l-arginina |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2811320B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
| FR2811318B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
| FR2811319B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
| FR2838648B1 (fr) * | 2002-04-18 | 2004-05-21 | Servier Lab | Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent |
| FR2841140B1 (fr) * | 2002-06-24 | 2004-10-01 | Servier Lab | Microcapsules pour la liberation retardee et controlee du perindopril |
-
2006
- 2006-02-28 FR FR0601747A patent/FR2897865B1/fr not_active Expired - Fee Related
-
2007
- 2007-02-26 CN CN2007800061997A patent/CN101389604B/zh active Active
- 2007-02-26 AU AU2007220434A patent/AU2007220434B2/en not_active Ceased
- 2007-02-26 WO PCT/FR2007/000334 patent/WO2007099216A2/fr active Application Filing
- 2007-02-26 AT AT07731038T patent/ATE465992T1/de active
- 2007-02-26 ME MEP-2010-330A patent/ME01805B/me unknown
- 2007-02-26 EA EA200801772A patent/EA014715B1/ru unknown
- 2007-02-26 MY MYPI20082990A patent/MY143557A/en unknown
- 2007-02-26 DK DK07731038.1T patent/DK2016051T3/da active
- 2007-02-26 SI SI200730264T patent/SI2016051T1/sl unknown
- 2007-02-26 UA UAA200811434A patent/UA89904C2/ru unknown
- 2007-02-26 KR KR1020087023636A patent/KR20080106947A/ko active Search and Examination
- 2007-02-26 RS RSP-2010/0330A patent/RS51431B/en unknown
- 2007-02-26 BR BRPI0708291A patent/BRPI0708291B8/pt active IP Right Grant
- 2007-02-26 EP EP07731038A patent/EP2016051B1/fr active Active
- 2007-02-26 ES ES07731038T patent/ES2345291T3/es active Active
- 2007-02-26 CA CA2643803A patent/CA2643803C/fr not_active Expired - Fee Related
- 2007-02-26 PL PL07731038T patent/PL2016051T3/pl unknown
- 2007-02-26 GE GEAP2007010917 patent/GEP20135839B/en unknown
- 2007-02-26 PT PT07731038T patent/PT2016051E/pt unknown
- 2007-02-26 NZ NZ570366A patent/NZ570366A/en not_active IP Right Cessation
- 2007-02-26 DE DE602007006176T patent/DE602007006176D1/de active Active
- 2007-02-26 MX MX2008010747A patent/MX2008010747A/es active IP Right Grant
- 2007-02-26 JP JP2008556811A patent/JP5611524B2/ja active Active
- 2007-02-26 US US12/224,415 patent/US7923569B2/en active Active
-
2008
- 2008-08-13 NO NO20083506A patent/NO341238B1/no unknown
- 2008-08-14 ZA ZA200807025A patent/ZA200807025B/xx unknown
- 2008-09-11 MA MA31233A patent/MA30277B1/fr unknown
-
2009
- 2009-08-24 HK HK09107754.2A patent/HK1129668A1/xx not_active IP Right Cessation
-
2010
- 2010-06-14 CY CY20101100547T patent/CY1110082T1/el unknown
- 2010-06-28 HR HR20100357T patent/HRP20100357T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1129668A1 (bg) | ||
| TW200736197A (en) | New crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| TW200736198A (en) | New crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| AR034124A1 (es) | Forma cristalina alfa de la sal de terbutilamina de perindopril, procedimiento para su preparacion y composiciones farmaceuticas que la contienen | |
| UA83720C2 (ru) | Кристаллическая форма v агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит | |
| PH12015502825B1 (en) | Crystals | |
| SI2311805T1 (sl) | Nova polimorfna oblika bazedoksifenijevaga acetata | |
| GEP20105086B (en) | Potassium salt of an hiv integrase inhibitor | |
| MX2009003698A (es) | Preparacion de azoxistrobina. | |
| UA93531C2 (en) | Novel hydrogen sulfate salt | |
| NO20064212L (no) | Piperidinyl som retter seg mot forbindelser som selektivt binder integriner | |
| GEP20125433B (en) | α CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT | |
| MX2009003257A (es) | Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina. | |
| RS53057B (en) | NEW CRYSTAL FORM 3- (difluoromethyl) -1-methyl-N- (3`, 4`, 5`-trifluoro [1,1`-biphenyl] -2-yl) -1H-pyrazole-4-carboxamide | |
| TW200800986A (en) | Tetrahydroquinolines, synthesis thereof, and intermediates thereto | |
| IL189883A0 (en) | Isoquinolines as igf-1r inhibitors | |
| WO2008101247A3 (en) | 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity | |
| WO2007016029A3 (en) | Diazepinoquinolines, synthesis thereof, and intermediates thereto | |
| TW200724642A (en) | Metal salts of quinolinols and quinolinol derivatives as adhesion and conductivity promoters in die attach adhesives | |
| MD20120130A2 (en) | Delta crystalline form of the L-arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it | |
| TW200616624A (en) | 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity | |
| RS51147B (sr) | Poboljšani postupak za prečišćavanje perindoprila | |
| TW200712163A (en) | Metal salts of maleimide compounds as conductivity promoters | |
| WO2008081104A3 (fr) | Conglomerats de sels de potassium du tenatoprazole | |
| MY142738A (en) | Preparation method of a novel beta crystalline form of perindopril tert-butylamine salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20240223 |